However, while PSMD3 mRNA levels were significantly reduced in AML versus normal cells, patients with higher PSMD3 expression levels demonstrated a significant reduction in OS, especially for AML patients harboring mutated FLT3 (p = 0.0015) (Figure 1F). The gene discussed is FLT3; the disease is acute myeloid leukemia.